Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionMycophenolate mofetil 250mg
CELLCEPT 250 MG / ML SUSPENSION
You Searched
CELLCEPT 250 MG / ML SUSPENSION
Roche Products India Pvt. Ltd.
₹8,000
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Prevention of organ rejection in transplant patients
Customers also bought
More About Cellcept
Benefits
In Prevention of organ rejection in transplant patients CELLCEPT 250 MG / ML SUSPENSION belongs to a group of medicines known as immunosuppressive agents. It lowers your immune response and reduces the chance of your body attacking the transplanted organ. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine may be used in combination with other medicines to suppress the immune system and help your body accept the new organ.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. CELLCEPT 250 MG / ML SUSPENSION can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
CELLCEPT 250 MG / ML SUSPENSION is an immunosuppressant. It reduces the action of the body's own defense system (the immune system) and prevents rejection of the transplanted organ.
Safe: No harmful side effects are associated with consuming alcohol alongside CELLCEPT 250 MG / ML SUSPENSION
Seek medical advice from your doctor: CELLCEPT 250 MG / ML SUSPENSION is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: CELLCEPT 250 MG / ML SUSPENSION is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
SAFE - CELLCEPT 250 MG / ML SUSPENSION does not usually affect your ability to drive.
Safe when prescribed by an expert: CELLCEPT 250 MG / ML SUSPENSION is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of CELLCEPT 250 MG / ML SUSPENSION may not be needed in these patients. Doctor consultation is advised.
Seek medical advice from your doctor: There is limited information available on the use of CELLCEPT 250 MG / ML SUSPENSION in patients with liver disease. Doctor consultation is advised.
Manufacturer Address
1503, 15th Floor, The Capital, Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051
References
Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1014-15
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 973
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 943-45
Mycophenolate mofetil. South San Francisco, California: Genentech USA, Inc.; 1995 (17 Jun. 2019)
Mycophenolate mofetil. Grenzach-Wyhlen, Germany: Roche Pharma AG; 2018 (17 Jun. 2019)
Central Drugs Standard Control Organisation. Mycophenolate mofetil (25 Jul. 2023)
Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993 Jul;56(1):75-82 (01 Aug. 2023)
Mycophenolate mofetil. Basel, Switzerland: F. Hoffmann-La Roche Ltd.; 2021 (25 Jul. 2023)
Cell Cept. Mycophenolate mofetil (25 Jul. 2023)
Mycophenolate mofetil (25 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
